Determining the optimal steroid treatment regimen for COPD exacerbations : A review of the literature

No Thumbnail Available

Meeting name

Sponsors

Journal Title

Format

Article

Subject

Research Projects

Organizational Units

Journal Issue

Abstract

In reviewing the literature, there is not a uniform approach to corticosteroid treatment when managing patients with COPD exacerbations. In general it is important to remember: Oral corticosteroids are as effective as IV corticosteroids in the management of most COPD exacerbations not requiring ICU admission. -- Short courses of prednisone (40mg daily for 5 days) are appropriate for most COPD exacerbations. -- Patients with frequent exacerbations of 2 or more per year or patients on chronic steroids may require a prolonged course of treatment. -- ICU patients have largely been excluded or not specifically studied in most analyses. Available literature shows that this subset of patients may benefit most from high-dose IV therapy for the first few days of treatment. Once patients are clinically improving, it would be reasonable to deescalate to oral therapy to limit unnecessary exposure.

Table of Contents

DOI

PubMed ID

Degree

Thesis Department

Rights

OpenAccess.

License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License.